Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) have received an average recommendation of "Buy" from the eight ratings firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company.
BAYRY has been the subject of a number of analyst reports. Zacks Research raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 10th. Deutsche Bank Aktiengesellschaft raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Thursday, July 2nd. Jefferies Financial Group upgraded Bayer Aktiengesellschaft to a "hold" rating in a report on Friday, May 29th. Finally, DZ Bank raised Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 19th.
View Our Latest Report on BAYRY
Bayer Aktiengesellschaft Stock Performance
OTCMKTS:BAYRY opened at $14.44 on Monday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.70 and a current ratio of 1.05. Bayer Aktiengesellschaft has a fifty-two week low of $7.40 and a fifty-two week high of $15.23. The company has a 50 day simple moving average of $12.64 and a two-hundred day simple moving average of $12.13. The company has a market capitalization of $56.75 billion, a PE ratio of -28.31, a P/E/G ratio of 4.52 and a beta of 0.55.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.06. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 17.00%. The firm had revenue of $12.53 billion for the quarter, compared to the consensus estimate of $12.31 billion. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. Research analysts anticipate that Bayer Aktiengesellschaft will post 1.28 earnings per share for the current year.
Bayer Aktiengesellschaft Company Profile
(
Get Free Report)
Bayer Aktiengesellschaft is a global life sciences company headquartered in Leverkusen, Germany, with a history dating back to 1863. The company operates across three principal business areas—Pharmaceuticals, Consumer Health and Crop Science—serving customers and markets worldwide. Bayer develops, manufactures and markets prescription medicines, over-the-counter healthcare products and agricultural solutions, and maintains research and development programs focused on new therapies and technologies in its core fields.
In Pharmaceuticals, Bayer focuses on prescription drugs across therapeutic areas such as cardiology, oncology, hematology and women's health, supporting clinical development and regulatory activities for both marketed products and pipeline candidates.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
